In medicine, Tetrapodal zinc oxide is more than just an ingredient in skincare products – it is a pioneer in medical innovation.
We have developed Phi-Stone Microbivac® t-ZnO in accordance with the highest standards of„Good Manufacturing Practice“ (GMP). It fulfills the quality requirements as an Active Pharmaceutical Ingredient (API) for medical use.
With its unique 3D micro morphology, the active ingredient potentially opens new horizons for the virus control and immunotherapy and can be used in pharmaceutical, dermatological and cosmetic products such as cremes, powders and ointments. Our self-developed wound protection gel Afinovir® is a current example of an approved medical product based on Microbivac®.
With its unique micro- and nanoscale 3D-morphology, the active ingredient opens new horizons for the virus control and immunotherapy and can be used in pharmaceutical, dermatological and cosmetic products such as cremes, powders and ointments. Our self-developed wound protection gel Afinovir® is a current example of an approved medical product based on Microbivac®.
Studies have found the evidence of the special binding mechanism of ZnO tetrapods. Especially after irradiation with UV light, oxygen vacancies are induced on the crystal surface, which further enhances the antiviral properties. This revolutionary concept has already shown a number of in—vitro and in-vivo results. In addition, an immune response can be induced as soon as the viruses are bound to the tetrapods.
Revolutionary approaches
In addition, ZnO-tetrapods can support wound healing, which opens up various other areas of application. The viruses bound in ZnO-tetrapods are taken up by dendritic cells, which may open new avenues for vaccines and immunotherapies. The versatility and the unique properties of ZnO-tetrapoden provide a solid basis for the development of therapies that could improve the lives of many.
Your industry – our solutions
Cosmetics / Pharmaceuticals: Pioneer in pharmaceutical innovation
“The cooperation with Phi-Stone AG was excellent. The tetrapodal zinc oxide for our acne serum has exceeded our expectations and is a major contributor to the success of our product. We are looking forward to work on further projects with Phi-Stone AG.”
– Kan Fu, CEO, KES Pharma GmbH
“Phi-Stone AG is an outstanding partner in research and development. The committed and competent team makes a significant contribution to both of our successes. I’m already looking forward to further successful projects.”
– Prof. Dr. Ulrich Mrowietz, University hospital Schleswig-Holstein
“Yesterday I got a cold sore and immediately treated it with Afinovir. No pain, it hasn’t grown and the cream is hardly noticeable. I am very satisfied. Sensational product – keep up the good work! We are looking forward to everything that is yet to come.”
– Dieter Stoffel, General Manager, Günter Stoffel Medizintechnik GmbH
Bitte bestätigen
Diese Website verlassen und folgende Seite öffnen: